Both use electrolysis of one type or another in their process as you've stated so here's some points on that :
A) Electralith state that a very large solar array is needed to power the process as an alternative to baseload supply as a cost saving measure with out this cost saving the process is uneconomical . I put it to you when applied to MANs claims how and where would this happen ?
Electroflow don't state renewables so one has to assume baseload power is required but they conveniently give no hint on economics either the processes are not dissimilar so again how and where ?
B) Electrolysis is not lithium selective so the membrane would act like a sieve IMO in the brine soup where there would be an anode and a cathode where +ve and -ve charged elements would move to either the anode or cathode and the membrane.
In a lab environment the unwanted elements can be dealt with easily because of small scale but when it's applied at commercial scale to MANs Paradox brines which I might add could historically have upto 40% total dissolved solids this is the possible outcome , for every 1 Mt of elemental lithium you extract @ 140ppm or 0.014% TDS you also extract 2,857.14 Mt 40% TDS of unwanted waste elements clinging charged to either an anode cathode or membrane .
Sure you could reverse the Electrolysis process but then you would get the opposite effect what you wouldn't get is your original suspension of individual elements as TDS .
This allies to both companies.
Safe to I'm not convinced and plenty more work is needed to change my mind .
Hope this helps you
Warmest Regards TT
- Forums
- ASX - By Stock
- ElectraLith vs Electroflow
MAN
mandrake resources limited
Add to My Watchlist
0.00%
!
1.8¢

Both use electrolysis of one type or another in their process as...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.29M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3097191 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 580889 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2797191 | 0.017 |
5 | 1076268 | 0.016 |
3 | 1070000 | 0.014 |
1 | 80000 | 0.012 |
1 | 450000 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 580889 | 2 |
0.020 | 1707920 | 6 |
0.021 | 51168 | 2 |
0.022 | 1015601 | 2 |
0.023 | 913465 | 3 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
MAN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online